Industry Focus

Latest Episodes:

Healthcare: 3 Been-There-Done-That Biotech CEOs That Are Doing it Again Jul 19, 2017

Show notes

After Puma Biotech's recent success, the search is on for other clinical-stage biotech stocks being run by proven CEOs. Could experience turn Aurinia Pharmaceuticals, Axovant Sciences, and Esperion Therapeutics into winners too?

Thanks to Slack for supporting Motley Fool. Learn more at slack.com.

CG: Listener Mailbag Edition Jul 18, 2017

Show notes

We field Foolish questions from the world of consumer and retail. First, Levi wants to know about the prospects for apparel retailer Buckle (and its double-digit dividend yield). Meanwhile, Shubhra is curious about Kirkland Signature and why the Costco private label is available on Amazon.com.

Thanks to Harry’s for supporting Industry Focus. Get your Free Trial Set -- go to Harrys.com/fool.

Financials: Cryptic Currencies with Brian Patrick Eha Jul 17, 2017

Show notes

Brian Patrick Eha, author of How Money Got Free, joins Gaby Lapera to discuss cryptocurrencies, tokens, blockchain technology, and what it all means for investors, regulators, and financial systems.

Thanks to Slack for supporting Motley Fool. Learn more at slack.com.

Tech: IPNo's Jul 14, 2017

Show notes

We love covering IPOs, but we can't bring ourselves to buy a stock that's only been publicly traded for a few months. We explain why on the final episode of "never will I ever week."

Energy: Never Will I Ever Buy a Commodity Stock That’s Not a Low Cost Producer Jul 13, 2017

Show notes

We all make investing mistakes, but buying a commodity producer lacking a cost advantage shouldn’t be one of them.

Healthcare: Never Will I Ever Buy Pre-Clinical Biotech Stocks. No Way! Jul 12, 2017

Show notes

Only 10% of drugs make it across the FDA finish line from phase 1 clinical trials, making acquiring pre-clinical biotech stocks the riskiest game in town.

CG: Never Will I Ever “Trade” Jul 11, 2017

Show notes

We continue with our theme for this week, as Asit Sharma explains the major hurdles day traders and speculators face in their pursuit of easy profits.

Things We'd Never Do Jul 10, 2017

Show notes

In this episode of Industry Focus: Financials, we dig into things we'd never do -- or, at least, that we try to avoid. This includes investing advice, as well as pointers about life more generally.

Tech: Summer Reading (and Listening) List Jul 07, 2017

Show notes

Looking for a beach read or a podcast to pass the time on the family trip? We run through some of our favorite tech books and shows so you can still get your fix during the slow months of summer.

Thanks to Slack for supporting Motley Fool. Learn more at slack.com.

Energy: Why Exxon Mobil Paid $5.6 billion to 1 of US’s Richest Families to Expand Its Permian Shale Presence Jul 06, 2017

Show notes

Is being late better than never arriving for America's biggest oil major?

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected